These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15177461)

  • 1. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
    Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3501-5. PubMed ID: 15177461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists.
    Hale JJ; Doherty G; Toth L; Li Z; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3495-9. PubMed ID: 15177460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
    J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
    Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
    Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
    Clemens JJ; Davis MD; Lynch KR; Macdonald TL
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors.
    Kim K; Kim YL; Sacket SJ; Kim HL; Han M; Park DS; Lee BK; Lee WK; Ha HJ; Im DS
    J Pharm Pharmacol; 2007 Jul; 59(7):1035-41. PubMed ID: 17637200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
    Sanna MG; Wang SK; Gonzalez-Cabrera PJ; Don A; Marsolais D; Matheu MP; Wei SH; Parker I; Jo E; Cheng WC; Cahalan MD; Wong CH; Rosen H
    Nat Chem Biol; 2006 Aug; 2(8):434-41. PubMed ID: 16829954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
    Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
    J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis.
    Li QF; Wu CT; Guo Q; Wang H; Wang LS
    Biochem Biophys Res Commun; 2008 Jun; 371(1):159-62. PubMed ID: 18423379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T; Igarashi Y
    Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
    Whetzel AM; Bolick DT; Srinivasan S; Macdonald TL; Morris MA; Ley K; Hedrick CC
    Circ Res; 2006 Sep; 99(7):731-9. PubMed ID: 16960101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
    Yan L; Hale JJ; Lynch CL; Budhu R; Gentry A; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala SM
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4861-6. PubMed ID: 15341940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold.
    Koide Y; Uemoto K; Hasegawa T; Sada T; Murakami A; Takasugi H; Sakurai A; Mochizuki N; Takahashi A; Nishida A
    J Med Chem; 2007 Feb; 50(3):442-54. PubMed ID: 17266196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
    Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
    Hale JJ; Lynch CL; Neway W; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Parent SA; Chrebet G; Bergstrom J; Card D; Ferrer M; Hodder P; Strulovici B; Rosen H; Mandala S
    J Med Chem; 2004 Dec; 47(27):6662-5. PubMed ID: 15615513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A; Pfeilschifter J
    Biochem Pharmacol; 2008 May; 75(10):1893-900. PubMed ID: 18321471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons.
    Zhang YH; Fehrenbacher JC; Vasko MR; Nicol GD
    J Neurophysiol; 2006 Sep; 96(3):1042-52. PubMed ID: 16723416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.